Tirzepatide 4-week results: what actually happens in the first month

Tirzepatide starts at a 2.5 mg tolerability dose — the first pen's job is adjustment, not maximum effect.
Appetite changes often arrive before noticeable weight loss; reduced hunger and earlier fullness are early signs the medicine is working.
The 2.5 mg starting dose is typically held for four weeks before the prescriber considers stepping up.
Clinical trial data show the largest weight reductions accumulate between months three and eighteen, not in week four.

Most people taking tirzepatide see modest but real changes within the first four weeks, typically between 2 and 5 kg of weight loss, though the number on the scale is only part of the story. That first month is deliberately a settling-in period: appetite begins to shift, eating habits start to change, and your body adjusts to a medicine that works across two gut-hormone pathways at once. These are prescription-only medicines; a GPhC-registered prescriber assesses whether tirzepatide is clinically suitable for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A practical, week-by-week picture of the first four weeks on tirzepatide

Step 1: the first injection and the first few days

Your first tirzepatide injection is 2.5 mg. That dose exists specifically to give your digestive system time to adapt, so the experience in days one to seven is rarely dramatic. Many people notice mild nausea, a slightly off feeling after meals, or less interest in food they normally enjoy. These are common GI effects documented in clinical studies and listed on the NHS tirzepatide medicines page — they tend to be most noticeable in the 24 to 48 hours after each injection, then ease.

Some people feel very little in week one at all. That is not a sign the medicine is not working; 2.5 mg is below the therapeutic range where significant weight loss is expected. If you are keen to understand how the first seven days tend to unfold, the week-one breakdown covers that in more detail.

Practically: inject on the same day each week. Some people pick a morning before the school run, others a Sunday evening, consistency matters more than the specific time.

Step 2: weeks two and three, appetite starts to shift

By the second and third week, the appetite effect becomes clearer for most people. Tirzepatide activates both GIP and GLP-1 receptors, slowing how quickly the stomach empties and increasing the signals that tell your brain you have had enough. In practical terms, portions feel large sooner, snacking becomes less driven, and some foods that were easy to overeat become less appealing.

Weight loss at this stage is real but modest. A reduction of 1 to 3 kg by the end of week three is a reasonable expectation, though individual responses vary considerably based on starting weight, diet, hydration, and activity. Fluid changes also play a role early on, some of what the scale reflects in the first weeks is water rather than fat mass.

Side effects tend to peak around dose increases rather than continuing at a steady level. At 2.5 mg, most people find weeks two and three more comfortable than day two or three of week one. If nausea or GI discomfort is affecting daily life, that is a conversation for your prescriber, not something to push through silently.

Step 3: week four and what the four-week mark actually tells you

By the end of the fourth week, many people have lost somewhere between 2 and 5 kg. The NICE appraisal of tirzepatide (TA1026) draws on the SURMOUNT-1 trial, in which participants taking 15 mg reached an average body-weight reduction of around 20 to 21 percent over 72 weeks, but the four-week mark sits near the very beginning of that curve. The steeper reductions accumulate through months three to twelve and beyond.

What the four-week mark does tell you: whether the starting dose is tolerable, whether appetite is responding, and whether the daily routine of weekly injections fits your life. It does not tell you whether tirzepatide will work for you in the long run, because the 2.5 mg dose is not the maintenance dose for most people. Your prescriber will review your progress at this point before any decision about stepping up.

For a fuller picture of how results develop, the three-month results page covers the period when most people see more substantial change. And if you want to compare what tirzepatide produces overall, the tirzepatide weight-loss results overview covers the full evidence base.

What four weeks does not change, and what comes next

A single month on 2.5 mg is not the basis on which clinical decisions about long-term suitability are made. The prescriber's four-week review is a checkpoint, not a verdict. If you have lost some weight, feel that appetite is shifting, and tolerated the injection well, the next step is typically moving to 5 mg. Progress from there tends to accelerate.

Questions about cost as treatment continues are reasonable at this stage. The Mounjaro pricing context page sets out honestly what private treatment involves and how to read the numbers. The key point is that for a prescription medicine, clinical oversight and genuine supply chain are what actually protect you, price alone is the wrong measure.

If you are still weighing up whether tirzepatide is right for your situation, the guide on how long Mounjaro takes to work gives a longer timeline, and the Mounjaro overview covers everything from mechanism to eligibility. When you are ready to take the next step, you can start a free consultation with our prescribers, your answers are reviewed the same day by a named, GPhC-registered clinician.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions